Sean P. Tully
2018
In 2018, Sean P. Tully earned a total compensation of $3.1M as Global Head of Financial and OTC Products at CME Group, a 15% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $18,001 |
|---|---|
| Non-Equity Incentive Plan | $787,185 |
| Salary | $450,000 |
| Stock Awards | $1,752,380 |
| Other | $76,270 |
| Total | $3,083,836 |
Tully received $1.8M in stock awards, accounting for 57% of the total pay in 2018.
Tully also received $18K of change in pension value and nonqualified deferred compensation earnings, $787.2K in non-equity incentive plan, $450K in salary and $76.3K in other compensation.
Rankings
In 2018, Sean P. Tully's compensation ranked 3,769th out of 14,244 executives tracked by ExecPay. In other words, Tully earned more than 73.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,769 out of 14,244 | 74th |
Division Finance, Insurance, And Real Estate | 692 out of 2,986 | 77th |
Major group Security And Commodity Brokers, Dealers, Exchanges, And Services | 109 out of 243 | 55th |
Source: SEC filing on March 20, 2019.
Tully's colleagues
We found four more compensation records of executives who worked with Sean P. Tully at CME Group in 2018.